Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Sepracor-Looks very promising -- Ignore unavailable to you. Want to Upgrade?

To: Don Miller who wrote (2000)	3/13/1999 4:09:00 PM
From: Bob Swift	Read Replies (3) \| Respond to of 10280

Just got back in town and glad I did not have to weather the ups and downs of the FTC probing. Does any one know exactly what is the extra information the FTC wants from Eli Lilly ? The LLY chat site is of no help. If indeed the S isomer of Prozac has different indication from the R-isomer, the R isomer should be and can be marketed as a new drug since the side effect (be it good or bad as long as the S isomer does something we do not yet understand to the body) is removed. I think we are pretty safe with our Prozac ICE.